[HTML][HTML] Fibrosis: from mechanisms to medicines

NC Henderson, F Rieder, TA Wynn - Nature, 2020 - nature.com
Fibrosis can affect any organ and is responsible for up to 45% of all deaths in the
industrialized world. It has long been thought to be relentlessly progressive and irreversible …

[HTML][HTML] Fibroblasts as immune regulators in infection, inflammation and cancer

S Davidson, M Coles, T Thomas, G Kollias… - Nature Reviews …, 2021 - nature.com
In chronic infection, inflammation and cancer, the tissue microenvironment controls how
local immune cells behave, with tissue-resident fibroblasts emerging as a key cell type in …

[HTML][HTML] Targeting the progression of chronic kidney disease

M Ruiz-Ortega, S Rayego-Mateos, S Lamas… - Nature Reviews …, 2020 - nature.com
Chronic kidney disease (CKD) is a devastating condition that is reaching epidemic levels
owing to the increasing prevalence of diabetes mellitus, hypertension and obesity, as well …

The immunology of hypertension

AE Norlander, MS Madhur, DG Harrison - Journal of Experimental …, 2018 - rupress.org
Although systemic hypertension affects a large proportion of the population, its etiology
remains poorly defined. Emerging evidence supports the concept that immune cells become …

Mesenchymal stem cells in fibrotic diseases—the two sides of the same coin

L Qin, N Liu, C Bao, D Yang, G Ma, W Yi… - Acta Pharmacologica …, 2023 - nature.com
Fibrosis is caused by extensive deposition of extracellular matrix (ECM) components, which
play a crucial role in injury repair. Fibrosis attributes to~ 45% of all deaths worldwide. The …

The yin and yang of IL-17 in systemic sclerosis

L Wei, D Abraham, V Ong - Frontiers in Immunology, 2022 - frontiersin.org
IL-17 (IL-17A) is a pro-inflammatory cytokine produced by a sub-set of T helper cells termed
Th17 cells primarily in response to cytokines like TGF-β and IL-23 and play an important role …

Review on inflammation markers in chronic kidney disease

T Petreski, N Piko, R Ekart, R Hojs, S Bevc - Biomedicines, 2021 - mdpi.com
Chronic kidney disease (CKD) is one of the major health problems of the modern age. It
represents an important public health challenge with an ever-lasting rising prevalence …

Complement C3 produced by macrophages promotes renal fibrosis via IL-17A secretion

Y Liu, K Wang, X Liang, Y Li, Y Zhang… - Frontiers in …, 2018 - frontiersin.org
Complement synthesis in cells of origin is strongly linked to the pathogenesis and
progression of renal disease. Multiple studies have examined local C3 synthesis in renal …

COVID-19. Pandemic surgery guidance

BLDM Brücher, G Nigri, A Tinelli, J Florencio… - 4 OPEN, 2020 - iris.uniroma1.it
Based on high quality surgery and scientific data, scientists and surgeons are committed to
protecting patients as well as healthcare staff and hereby provide this Guidance to address …

Interleukin 17A participates in renal inflammation associated to experimental and human hypertension

M Orejudo, RR Rodrigues-Diez… - Frontiers in …, 2019 - frontiersin.org
Hypertension is now considered as an inflammatory disease, and the kidney is a key end-
organ target. Experimental and clinical studies suggest that interleukin 17A (IL-17A) is a …